New Test Helps Breast Cancer Survivors Determine Treatment Course
February 18, 2015
Breast Cancer Index (Screening Test)
Being diagnosed with breast cancer is scary and stressful for women and their families. But oftentimes what might come next is equally stressful. Women wonder if their cancer will come back or if staying on extended anti-estrogen therapies is really worth all of the side effects. Now there is a simple test that is helping to provide answers for doctors and patients. Please join us as we welcome Dr. Ann Stroh, a Medical Oncologist, and Dr. Catherine Schnabel from bioTheranostics, who are here with the latest in personalized medicine.
Bringing the best tips from the experts in Atlanta in business, beauty, wealth management, child healthcare, car shopping, and more. Each year, Atlanta’s Women’s Entrepreneurship Initiative selects 15 local female entrepreneurs for a 15-month business training program. We meet women who have grown their companies, created jobs, and broke through the glass ceiling. With some […]
iMCD is the deadliest subtype of Castleman disease. Approximately one third of patients die within five years of diagnosis, and another third die within 10 years if not treated.
There are no effective treatment options for people with unresectable or metastatic chondrosarcoma despite many attempts by multiple pharmaceutical companies over the past few decades.